ASX Ltd share price sinks 3.7% – Is it a bargain?

ASX Ltd (ASX:ASX) is a high-quality business than could have entered buy territory.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: The share price of stock exchange operator ASX Ltd (ASX: ASX) is down 3.7% at midday on Friday as investors around the globe remove risk from their portfolios.

Overnight on Wall Street the Dow Jones lost 1.4%, while in Europe the FTSE slumped 2.2% and the DAX plunged 3.6%.

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has followed the offshore leads today to trade 1.8% lower at lunchtime.

So What: Given ASX Ltd's leverage to equity markets it is understandable that the stock has fallen more than the index today in response to the market-wide slump. With the share price well off its 52-week high however, the stock could now be worth a closer look.

Here's what investors learned this week about the group's November trading activity:

  • In November $7.9 billion of capital was raised
  • The average daily number of trades was 21% higher than the prior corresponding period (pcp)
  • The average daily value traded on-market was 15% higher than the pcp at $4 billion
  • The average daily future and options on futures volume increased 28% on the pcp

Now What: With a monopoly and near monopoly position in the provision of numerous domestic security exchange services, the ASX offers investors exposure to a business model with an entrenched and compelling competitive advantage.

Based on consensus data supplied by Morningstar, the company is forecast to earn 217.6 cents per share (cps) in financial year 2016 and pay a dividend totalling 195.9 cps.

With the stock down as low as $40.51 this morning, these forecasts imply an appealing looking forward price-to-earnings ratio and fully franked yield of 18.6x and 4.8% respectively.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »